Potential of Zerumbone as an Anti-Cancer Agent

Area of Science:

• Phytochemistry
• Pharmacology
• Oncology

Background:

• Cancer remains a global health burden with limited effective treatments due to selectivity issues and side effects.
• Natural compounds offer potential alternative therapies with fewer adverse effects.
• Zerumbone, derived from Zingiber zerumbet, exhibits diverse pharmacological activities.

Purpose of the Study:

• To review the anti-cancer properties of zerumbone.
• To summarize its mechanisms of action against various cancers.
• To highlight its therapeutic potential as a novel anti-cancer agent.

Main Methods:

• Literature review of studies on zerumbone's anti-cancer effects.
• Analysis of molecular pathways targeted by zerumbone, including NF-κB, Akt, and IL-6/JAK2/STAT3.
• Summary of evidence for zerumbone's impact on cancer proliferation, survival, angiogenesis, invasion, and metastasis.

Main Results:

• Zerumbone demonstrates significant suppression of cancer cell proliferation, survival, angiogenesis, invasion, and metastasis.
• It modulates key molecular pathways (NF-κB, Akt, IL-6/JAK2/STAT3) involved in cancer progression.
• Zerumbone exhibits antioxidant, antibacterial, anti-inflammatory, and immunomodulatory properties, contributing to its anti-cancer effects.

Conclusions:

• Zerumbone possesses considerable therapeutic potential as a safe and effective anti-cancer agent.
• Its ability to target multiple cancer hallmarks and molecular pathways makes it a promising candidate for drug development.
• Further research into zerumbone could lead to novel cancer treatment strategies.